MP70-12 AN INDIRECT TREATMENT COMPARISON AND COST-EFFECTIVENESS ANALYSIS OF ABIRATERONE ACETATE AND ENZALUTAMIDE FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER POST CHEMOTHERAPY

Author(s):

Melissa Thompson ◽

Tracy Li ◽

Mary Beth Todd ◽

Margaret K. Yu ◽

Thian Kheoh ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Abiraterone Acetate ◽

Indirect Treatment Comparison ◽

Treatment Comparison ◽

Castration Resistant ◽

Effectiveness Analysis ◽

Indirect Treatment

Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy with Docetaxel

Value in Health ◽

10.1016/j.jval.2014.08.2278 ◽

2014 ◽

Vol 17 (7) ◽

pp. A635

Author(s):

C.A. Obando ◽

Z. Desanvicente-Celis ◽

L. Gonzalez ◽

D. Muschett ◽

F. Gonzalez ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Costa Rica ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in Dominican Republic, in Patients With Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Value in Health ◽

10.1016/j.jval.2014.08.2279 ◽

2014 ◽

Vol 17 (7) ◽

pp. A635 ◽

Author(s):

C.A. Obando ◽

Z. Desanvicente-Celis ◽

L. Gonzalez ◽

D. Muschett ◽

F. Gonzalez ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Dominican Republic ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy: Cost Effectiveness Analysis

Value in Health ◽

10.1016/j.jval.2013.08.506 ◽

2013 ◽

Vol 16 (7) ◽

pp. A411 ◽

Author(s):

J. He ◽

T. Li ◽

R. Saadi

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to Chemotherapy with Docetaxel

Value in Health ◽

10.1016/j.jval.2014.08.2261 ◽

2014 ◽

Vol 17 (7) ◽

pp. A632 ◽

Author(s):

C.A. Obando ◽

Z. Desanvicente-Celis ◽

L. Gonzalez ◽

D. Muschett ◽

F. Gonzalez ◽

...

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Effectiveness Analysis ◽

The Republic

Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden

Value in Health ◽

10.1016/j.jval.2013.03.655 ◽

2013 ◽

Vol 16 (3) ◽

pp. A134-A135 ◽

Author(s):

U. Persson ◽

S. Nilsson ◽

C. Prûtz ◽

C. Hjortsberg

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Real Life ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Effectiveness Analysis ◽

Using Data

Cost-Effectiveness Analysis of Abiraterone Acetate as Second Line Treatment for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Treatment in Japan

Value in Health ◽

10.1016/j.jval.2013.08.532 ◽

2013 ◽

Vol 16 (7) ◽

pp. A415-A416 ◽

Author(s):

H. Shibahara ◽

T. Shiroiwa ◽

K. Nakamura ◽

K. Shimozuma

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Abiraterone Acetate ◽

Line Treatment ◽

Second Line ◽

Castration Resistant ◽

Effectiveness Analysis ◽

Docetaxel Treatment

Cost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Metastatic Castration-Resistant Prostate Cancer

Value in Health ◽

10.1016/j.jval.2014.03.482 ◽

2014 ◽

Vol 17 (3) ◽

pp. A82-A83

Author(s):

C.L. Gong ◽

J.W. Hay

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant ◽

Cost-effectiveness analysis of treatments for metastatic castration resistant prostate cancer

Asian Journal of Urology ◽

10.1016/j.ajur.2016.11.005 ◽

2017 ◽

Vol 4 (1) ◽

pp. 37-43 ◽

Cited By ~ 19

Author(s):

Matthew E. Pollard ◽

Alan J. Moskowitz ◽

Michael A. Diefenbach ◽

Simon J. Hall

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant ◽

Cost-Effectiveness Analysis of Abiraterone and Sipuleucel-T in Asymptomatic Metastatic Castration-Resistant Prostate Cancer

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2014.0139 ◽

2014 ◽

Vol 12 (10) ◽

pp. 1417-1425 ◽

Cited By ~ 15

Author(s):

Cynthia L. Gong ◽

Joel W. Hay

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant ◽

PCN153 - COST-EFFECTIVENESS ANALYSIS OF APALUTAMIDE FOR TREATMENT IN NON- METASTASIS CASTRATION-RESISTANT PROSTATE CANCER

Value in Health ◽

10.1016/j.jval.2018.09.236 ◽

2018 ◽

Vol 21 ◽

pp. S40-S41 ◽

Author(s):

Z. Zhou ◽

X. Hu

Keyword(s):

Prostate Cancer ◽

Cost Effectiveness ◽

Castration Resistant ◽